Article ; Online: Ambulant erworbene Pneumonie.
Deutsche medizinische Wochenschrift (1946)
2023 Volume 148, Issue 6, Page(s) 335–341
Abstract: Risk factors for severe courses: The CRB-65 score is recommended as a risk predictor, as well as consideration of unstable comorbidities and oxygenation.: Grouping of community-acquired pneumonia: Community-acquired pneumonia is divided into 3 groups: ...
Title translation | Community-acquired pneumonia. |
---|---|
Abstract | Risk factors for severe courses: The CRB-65 score is recommended as a risk predictor, as well as consideration of unstable comorbidities and oxygenation. Grouping of community-acquired pneumonia: Community-acquired pneumonia is divided into 3 groups: mild pneumonia, moderate pneumonia, severe pneumonia. Whether there is a curative vs palliative treatment goal should be determined early. Diagnostic recommendation: An X-ray chest radiograph is recommended to confirm the diagnosis, also in the outpatient setting if possible. Sonography of the thorax is an alternative, asking for additional imaging if negative. Streptococcus pneumoniae remains the most common bacterial pathogen. Therapy: Community-acquired pneumonia continues to be associated with high morbidity and lethality. Prompt diagnosis and prompt initiation of risk-adapted antimicrobial therapy are essential measures. However, in times of COVID-19, as well as the current influenza and RSV epidemic, purely viral pneumonias must also be expected. At least with COVID-19, antibiotics can often be avoided. Antiviral and anti-inflammatory drugs are used here. Post-acute course: Patients after community-acquired pneumonia have increased acute and long-term mortality due to cardiovascular events in particular. The focus of research is on improved pathogen identification, a better understanding of the host response with the potential of developing specific therapeutics, the role of comorbidities, and the long-term consequences of the acute illness. |
MeSH term(s) | Humans ; COVID-19 ; Pneumonia, Viral/diagnosis ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/therapy ; Community-Acquired Infections/diagnosis ; Community-Acquired Infections/therapy ; Anti-Bacterial Agents/therapeutic use ; Antiviral Agents |
Chemical Substances | Anti-Bacterial Agents ; Antiviral Agents |
Language | German |
Publishing date | 2023-03-06 |
Publishing country | Germany |
Document type | English Abstract ; Journal Article |
ZDB-ID | 200446-x |
ISSN | 1439-4413 ; 0012-0472 |
ISSN (online) | 1439-4413 |
ISSN | 0012-0472 |
DOI | 10.1055/a-1940-8944 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Ua VI Zs.60: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
|||
Ua VI Zs.60/X: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.